Cancer risk in HIV-infected persons: influence of CD4(+) count.
about
HIV infection, aging, and immune function: implications for cancer risk and preventionRelationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.Incidence and progression of cervical lesions in women with HIV: a systematic global review.Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.HIV infection, immunodeficiency, viral replication, and the risk of cancer.Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisitionDisseminated cutaneous Kaposi sarcoma in a patient receiving triptolide/tripdiolide for rheumatoid arthritis.Clinical and histopathologic characteristics of skin malignancies in Qassim Region, Saudi Arabia.Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this riskAssociation of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.Gut-homing α4β7 CD4+ T cells: potential key players in both acute HIV infection and HIV-associated cancers.
P2860
Q27004165-7DC62401-7E7B-4E26-AFF9-E934EC8E4C1EQ33696149-74B5964A-F29D-41C3-85C7-513FBF064CB5Q33728067-1A061574-B6E8-461E-B3F8-AFD2809C53F5Q33924965-DBBECA63-83C4-4B22-823C-6438BA00D176Q34774173-7B1A4418-1601-4111-92C4-1EF7AC715A3AQ35612742-A751F59F-88C2-4BBF-8ACC-BFB9E7882304Q36036666-1D1E6687-D558-4755-89BF-F62F84C2DB03Q36184954-19A1ED9A-C61A-48DF-B0DE-2659114512B0Q36577249-B9D6F68A-D740-4EB1-93D7-628853689012Q36728922-61F63B5A-905C-43AE-AB79-89557B5F27D0Q37712406-382DA02C-5714-4F2B-8130-01363FE3218AQ40250347-E036D633-2811-4119-8959-F09F10B7FF81Q41055765-31AD0862-D31C-4F68-95E5-8B917579D165Q42772427-984D4ECA-3CFC-40C2-8FFE-8A799EEDA4B4Q51732134-85D880D0-D6BA-4364-8B77-56E8F23984F7Q54326253-88329809-E3BF-45CC-BD0A-0D0C5DBBC424
P2860
Cancer risk in HIV-infected persons: influence of CD4(+) count.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer risk in HIV-infected persons: influence of CD4
@nl
Cancer risk in HIV-infected persons: influence of CD4(+) count.
@en
type
label
Cancer risk in HIV-infected persons: influence of CD4
@nl
Cancer risk in HIV-infected persons: influence of CD4(+) count.
@en
prefLabel
Cancer risk in HIV-infected persons: influence of CD4
@nl
Cancer risk in HIV-infected persons: influence of CD4(+) count.
@en
P2860
P356
P1433
P1476
Cancer risk in HIV-infected persons: influence of CD4(+) count.
@en
P2093
Gary M Clifford
P2860
P304
P356
10.2217/FON.09.28
P407
P577
2009-06-01T00:00:00Z